Comparative Effectiveness of School-based Caries Prevention

Sponsor
NYU College of Dentistry (Other)
Overall Status
Recruiting
CT.gov ID
NCT03442309
Collaborator
Patient-Centered Outcomes Research Institute (Other), Boston University (Other), New York City Department of Health and Mental Hygiene (Other)
14,100
1
2
51.9
271.5

Study Details

Study Description

Brief Summary

Dental caries (tooth decay) is the most prevalent childhood disease in the world. Multiple interventions are available to treat and prevent caries. The aim of the proposed study is to compare the benefit of silver diamine fluoride (SDF) and fluoride varnish versus fluoride varnish and glass ionomer sealants. This study is a five-year, cluster randomized, pragmatic controlled trial conducted in public elementary schools in New York City.

Condition or Disease Intervention/Treatment Phase
  • Device: Silver Diamine Fluoride
  • Device: Fluoride Varnishes
  • Device: Glass Ionomer
N/A

Detailed Description

Dental caries is the most prevalent childhood disease in the world and can lead to infection, pain, reduced quality of life, and negative educational outcomes. Multiple prevention agents are available to arrest and prevent dental caries, however little is known of the comparative effectiveness of combined treatments in pragmatic settings. The aim of the presented study is to compare the benefit of silver diamine fluoride and fluoride varnish versus fluoride varnish and glass ionomer therapeutic sealants in the arrest and prevention of dental caries.

This is a longitudinal, pragmatic, cluster randomized, single-blind, non-inferiority trial to be conducted in low-income minority children enrolled in public elementary schools in New York City, New York, United States, from 2018-2023. The primary objective is to assess the non-inferiority of alternative agents in the arrest and prevention of dental caries. Secondary objectives are to assess oral health-related quality of life and educational outcomes. Caries arrest will be evaluated after two years, and caries prevention and secondary outcomes will be assessed at the completion of the study. Data analysis will follow intent to treat, and statistical analyses will be conducted using a two-sided significance level of 0.05.

Notably, the standard of care for dental caries is office-based surgery, which presents multiple barriers to care including cost, fear, and geographic isolation. The simplicity and affordability of silver diamine fluoride may be a viable alternative for the arrest and prevention of dental caries in high-risk children.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
14100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Two-arm, parallel, non-inferiority cluster randomized trialTwo-arm, parallel, non-inferiority cluster randomized trial
Masking:
Single (Outcomes Assessor)
Masking Description:
The investigators responsible for analyzing the data for primary outcomes will be masked.
Primary Purpose:
Prevention
Official Title:
Silver Diamine Fluoride Versus Therapeutic Sealants for the Arrest and Prevention of Dental Caries in Low-income Minority Children
Actual Study Start Date :
Feb 1, 2019
Anticipated Primary Completion Date :
Jun 1, 2023
Anticipated Study Completion Date :
Jun 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Simple Prevention

One drop (0.05 ml) of silver diamine fluoride (Advantage ArrestTM) solution at 38% concentration (2.24 F-ion mg/dose) will be dispensed per child. Posterior tooth surfaces to be treated will be dried, after which the SDF will be applied with a micro-brush to all asymptomatic carious lesions and to all pits and fissures on bicuspids and molar teeth for thirty seconds. Fluoride varnishes (5% NaF) will then be applied to all teeth. Dosage frequency will be twice-yearly.

Device: Silver Diamine Fluoride
Silver diamine fluoride (SDF)
Other Names:
  • Advantage Arrest
  • Device: Fluoride Varnishes
    Fluoride varnish (FV)

    Active Comparator: Complex prevention

    Pits and fissures on all bicuspids and molar teeth will be sealed with glass ionomer sealants (GC Fuji IX). Glass ionomer sealants (interim therapeutic restorations) will also be placed on all frank asymptomatic carious lesions. Fluoride varnishes (5% NaF) will then be applied to all teeth. Dosage frequency will be twice-yearly.

    Device: Fluoride Varnishes
    Fluoride varnish (FV)

    Device: Glass Ionomer
    Glass Ionomer Sealants (GC Fuji IX)

    Outcome Measures

    Primary Outcome Measures

    1. Arrest of dental caries as measured by clinical oral examination [Two years]

      For any untreated dental caries on teeth at baseline treated with SDF/FV or Glass ionomer/FV to arrest (control) the infection, what is the proportion of treated (arrested) caries that stayed arrested

    2. Prevention of dental caries as measured by a clinical oral examination [5 years]

      For teeth without carious lesions (sound) treated with SDF/FV or Glass Ionomer/FV, what proportion of teeth stayed sound

    Secondary Outcome Measures

    1. Oral Health-Related Quality of Life [5 years]

      Child oral health-related quality of life (e.g., functioning, social stigma, socio-emotional) as measured using the Child Oral Health Impact Profile - Short Form (COHIP-SF)

    2. Student achievement on standardized math and English exams [5 years]

      Student achievement on math and English standardized examinations conducted from grades 3-8 given by the New York City Department of Education

    3. School attendance [5 years]

      Annual school attendance per-participant as recorded by the New York City Department of Education

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    5 Years to 12 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Any primary school in New York City with a Hispanic/Latino student population greater than 50% and,

    • A low-income population (defined as a student receiving free or reduced price lunch) of at least 80%.

    • Within participating schools, all children are eligible to participate in the study.

    Exclusion Criteria:
    • Schools that already have a pre-existing school-based dental health program.

    • Within participating schools, exclusion criteria for children include those without informed consent or those with consent but without assent.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 New York University College of Dentistry New York New York United States 10010

    Sponsors and Collaborators

    • NYU College of Dentistry
    • Patient-Centered Outcomes Research Institute
    • Boston University
    • New York City Department of Health and Mental Hygiene

    Investigators

    • Principal Investigator: Richard Niederman, DMD, NYU Langone Health
    • Principal Investigator: Ryan R Ruff, PhD, NYU Langone Health

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    Richard Niederman, Professor, NYU College of Dentistry
    ClinicalTrials.gov Identifier:
    NCT03442309
    Other Study ID Numbers:
    • i17-00578
    First Posted:
    Feb 22, 2018
    Last Update Posted:
    Oct 8, 2020
    Last Verified:
    Oct 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Richard Niederman, Professor, NYU College of Dentistry
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 8, 2020